As a board certified physician, he is specialized in Molecular Genetic Pathology and Clinical Informatics. With trainings and working experience in clinical, biomedical sciences and computer sciences, he has broad expertise in molecular medicine and bioinformatics, especially in cancer research, biomarker discovery and drug development. Currently, his research primarily focuses on MDS and AML. He has successfully conducted a number of clinical and translational research projects and published in peer-reviewed journals.